Project Grant R01NS147997
- Federal Project Grant Award Summary Mayo Clinic Jacksonville received a $161,300 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 24, 2026, with completion targeted for August 23, 2027. The grant supports research aimed at decoding and targeting molecular mechanisms of TRAF7/KLF4 driver mutations in meningioma, addressing a...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Miami $599,005 on August 21, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support a five-year research project extending through July 31, 2030. The award funds mechanistic research investigating the role of NFKBIA (IκBα) deficiency in glioma development, with particular focus on how NFKBIA...
- Federal Project Grant Summary Mayo Clinic received a $1.27M Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025 through April 30, 2030. This R01 research project focuses on engineering antibody drug conjugates (ADCs)—a class of molecularly targeted therapeutics that deliver potent toxins directly to tumor...
- Federal Grant Award Summary Award Details: The National Institute of Neurological Disorders and Stroke (NINDS) awarded $439,239 to Beckman Research Institute of the City of Hope under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project grant was awarded July 1, 2025, with a completion date of June 30, 2030. Products and Services: The award funds development and feasibility testing of REMIDE (Robotic Evacuation and Minimally Invasive...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the Regents of the University of Minnesota a Project Grant totaling $1,458,330 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through April 30, 2030. The award funds research to determine the spatial limits and strengths of neurovascular coupling across layers of the cerebral cortex using advanced...
- Federal Project Grant Award Summary Augusta University Research Institute, Inc. (AURI), doing business as Georgia Health Sciences, received a $462,933 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective January 1, 2026, through December 31, 2030. The award funds basic neuroscience research investigating spreading depolarization (SD)—waves of...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Washington University a Project Grant totaling $231,264.00 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, with an award date of April 8, 2026, and ultimate completion date of March 31, 2031. This research project focuses on identifying and validating cerebroprotective drug targets in human stroke patients by collecting and...
- Federal Project Grant Award Summary Neurovascular Diagnostics Inc. received a $430,957 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded September 16, 2025, with completion targeted for August 31, 2027. The award supports testing and validation of AneuscreenTM, a blood-based polymerase chain reaction (PCR) assay that uses gene expression...
- Federal Grant Award Summary Emory University received a $234,750 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2027. The project focuses on developing instantaneous digital subtraction angiography (DSA) technology for neurovascular applications to address cerebrovascular disease (CVD), which ranks as...
- Federal Project Grant Award Summary Mayo Clinic Jacksonville has been awarded $683,819 under the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) for a three-year project period from August 15, 2025 through August 14, 2028. The project, titled "Targeting the Polycomb Repressive Complex 2 in Neurofibromatosis Type 2 and Schwannomatosis," will be conducted at the organization's Jacksonville, Florida facility under the direction of Scott Lynch, MD....
Award Details: Mayo Clinic Jacksonville received a Project Grant award of $442,086.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award was obligated on May 13, 2026, with an ultimate completion date of April 30, 2029. Products and Services: This project delivers research services focused on analyzing carotid atherosclerotic plaque morphologic characteristics to improve patient selection for carotid revascularization procedures in the context of the CREST-2 clinical trial. The primary products include: (1) standardized image analysis of 2,000 baseline carotid duplex ultrasound (DUS) studies to evaluate relationships between plaque morphologic traits and periprocedural stroke or death outcomes; and (2) longitudinal characterization of how intensive medical management affects plaque morphologic features over time in 500 patients. These research services leverage the Vascular Imaging Core's archived B-mode ultrasound images and established image analysis algorithms to provide clinical evidence supporting improved risk stratification for asymptomatic high-grade carotid stenosis patients.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $442.1k | 5/14/26 |